Yanguo Su

487 total citations
18 papers, 363 citations indexed

About

Yanguo Su is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Yanguo Su has authored 18 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Biomedical Engineering. Recurrent topics in Yanguo Su's work include Nanoplatforms for cancer theranostics (6 papers), Immune cells in cancer (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Yanguo Su is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Immune cells in cancer (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Yanguo Su collaborates with scholars based in China. Yanguo Su's co-authors include Daquan Chen, Chunjing Guo, Huimin Guo, Changgang Sun, Qiang Chen, Zhenfeng Wu, Xue Liu, Jinqiu Wang, Hongjie Mu and Ming Kong and has published in prestigious journals such as Small, Carbohydrate Polymers and International Journal of Biological Macromolecules.

In The Last Decade

Yanguo Su

18 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanguo Su China 12 138 84 82 48 36 18 363
Xiaoya Hou China 9 132 1.0× 114 1.4× 129 1.6× 61 1.3× 40 1.1× 10 401
Kaipei Luo China 11 147 1.1× 103 1.2× 119 1.5× 55 1.1× 26 0.7× 15 354
Xin Guan China 13 186 1.3× 50 0.6× 59 0.7× 38 0.8× 40 1.1× 31 404
Zhipeng Li China 14 190 1.4× 144 1.7× 145 1.8× 42 0.9× 28 0.8× 38 534
Mahdie Hemati Iran 11 167 1.2× 90 1.1× 118 1.4× 23 0.5× 34 0.9× 25 414
Farnoosh Attari Iran 12 234 1.7× 80 1.0× 65 0.8× 26 0.5× 32 0.9× 20 452
Giorgia Ailuno Italy 11 140 1.0× 62 0.7× 66 0.8× 22 0.5× 24 0.7× 25 412
Vladimíra Svobodová Pavlíčková Czechia 12 201 1.5× 85 1.0× 57 0.7× 34 0.7× 23 0.6× 23 420
Geanina Voicu Romania 10 127 0.9× 69 0.8× 63 0.8× 64 1.3× 14 0.4× 24 375

Countries citing papers authored by Yanguo Su

Since Specialization
Citations

This map shows the geographic impact of Yanguo Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanguo Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanguo Su more than expected).

Fields of papers citing papers by Yanguo Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanguo Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanguo Su. The network helps show where Yanguo Su may publish in the future.

Co-authorship network of co-authors of Yanguo Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yanguo Su. A scholar is included among the top collaborators of Yanguo Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanguo Su. Yanguo Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Dong, Yu, Bingjie Wang, Teng Wang, et al.. (2025). Dual Metal Nanoflower Oxygen Pump Microneedles Based on Cuproptosis and STING Pathway Activation for Cancer Immunotherapy. Small. 21(11). e2409187–e2409187. 11 indexed citations
2.
Su, Yanguo, Rui Chen, Bingjie Wang, et al.. (2025). Erythrocyte membrane camouflaged celastrol and bilirubin self-assembly for rheumatoid arthritis immunotherapy based on STING inhibition and RONS clearance. Journal of Nanobiotechnology. 23(1). 318–318. 5 indexed citations
3.
4.
Guo, Chunjing, Min Cao, Wenxin Wang, et al.. (2023). Novel pH-responsive E-selectin targeting natural polysaccharides hybrid micelles for diabetic nephropathy. Nanomedicine Nanotechnology Biology and Medicine. 52. 102696–102696. 8 indexed citations
5.
Guo, Chunjing, Wei Zhang, Yanguo Su, et al.. (2023). Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer. Artificial Cells Nanomedicine and Biotechnology. 51(1). 170–179. 14 indexed citations
6.
Xi, Yanhai, Yanyan Liu, Guohua Xu, et al.. (2023). α-Lipoic acid loaded hollow gold nanoparticles designed for osteoporosis treatment: preparation, characterization andin vitroevaluation. Artificial Cells Nanomedicine and Biotechnology. 51(1). 131–138. 14 indexed citations
7.
Su, Yanguo, Chunjing Guo, Qiang Chen, et al.. (2022). Construction of bionanoparticles based on Angelica polysaccharides for the treatment of stroke. Nanomedicine Nanotechnology Biology and Medicine. 44. 102570–102570. 11 indexed citations
8.
Su, Yanguo, Chunjing Guo, Qiang Chen, et al.. (2022). Novel multifunctional bionanoparticles modified with sialic acid for stroke treatment. International Journal of Biological Macromolecules. 214. 278–289. 15 indexed citations
9.
Guo, Chunjing, Yanguo Su, Ziting Cheng, et al.. (2022). Novel ROS-responsive marine biomaterial fucoidan nanocarriers with AIE effect and chemodynamic therapy. International Journal of Biological Macromolecules. 202. 112–121. 15 indexed citations
10.
Chen, Qiang, Chunjing Guo, Yanguo Su, et al.. (2022). N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis. International Journal of Biological Macromolecules. 211. 259–270. 23 indexed citations
11.
Li, Yi, Chunjing Guo, Qiang Chen, et al.. (2022). Improvement of pneumonia by curcumin-loaded bionanosystems based on platycodon grandiflorum polysaccharides via calming cytokine storm. International Journal of Biological Macromolecules. 202. 691–706. 43 indexed citations
12.
Liu, Hui, Chunjing Guo, Qiang Chen, et al.. (2022). Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Delivery. 29(1). 454–465. 54 indexed citations
13.
Guo, Chunjing, Yanguo Su, Huimin Guo, et al.. (2022). CD44 Receptor-Targeted and Reactive Oxygen Species-Responsive H2S Donor Micelles Based on Hyaluronic Acid for the Therapy of Renal Ischemia/Reperfusion Injury. ACS Omega. 7(46). 42339–42346. 7 indexed citations
14.
Guo, Chunjing, Huimin Guo, Yanguo Su, et al.. (2022). Celestrol-Loaded Nanoscale Micelles Derived from Dextran Sulfate/PVGLIG/Celestrol with MMP-2 Sensitivity for the Treatment of High-Fat-Diet-Induced Obesity. ACS Applied Nano Materials. 5(9). 13236–13244. 6 indexed citations
15.
Guo, Chunjing, Yanguo Su, Hui Wang, et al.. (2022). A novel saponin liposomes based on the couplet medicines of Platycodon grandiflorum–Glycyrrhiza uralensis for targeting lung cancer. Drug Delivery. 29(1). 2743–2750. 19 indexed citations
16.
Guo, Huimin, Yanguo Su, Chunjing Guo, et al.. (2022). Polysaccharide based drug delivery systems for Chinese medicines. Biocatalysis and Agricultural Biotechnology. 44. 102441–102441. 5 indexed citations
17.
Liu, Xue, Zhenfeng Wu, Chunjing Guo, et al.. (2021). Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy. Drug Delivery. 29(1). 138–148. 93 indexed citations
18.
Guo, Chunjing, Yanguo Su, Bingjie Wang, et al.. (2021). Novel polysaccharide building hybrid nanoparticles: remodelling TAMs to target ERα-positive breast cancer. Journal of drug targeting. 30(4). 450–462. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoya Hou Breakdown of academic impact, for papers by Kaipei Luo Breakdown of academic impact, for papers by Xin Guan Breakdown of academic impact, for papers by Zhipeng Li Breakdown of academic impact, for papers by Mahdie Hemati Breakdown of academic impact, for papers by Farnoosh Attari Breakdown of academic impact, for papers by Giorgia Ailuno Breakdown of academic impact, for papers by Vladimíra Svobodová Pavlíčková Breakdown of academic impact, for papers by Geanina Voicu
Rankless by CCL
2026